Survival Benefit from High-Dose Therapy with Autologous Blood Progenitor-Cell Transplantation in Poor-Prognosis Non-Hodgkin's Lymphoma

Journal of Clinical Oncology

Volumn 14, Issue 2, 1996, Pages 586-592

  Pettengell, R ^a   Radford, J A ^a   Morgenstern, G R ^a   Scarffe, J H ^a   Harris, M ^a   Woll, P J ^a   Deakin, D P ^a   Ryder, D ^a   Wilkinson, P M ^a   Crowther, D ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ADULT; ARTICLE; CANCER RISK; CANCER SURVIVAL; CELL TRANSPLANTATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BUSULFAN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; IFOSFAMIDE; METHOTREXATE; MIDDLE AGED; PREDNISOLONE; PROGNOSIS; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS; VINCRISTINE;

EID: 0030031130     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.2.586     Document Type: Article

References (26)

1. Fisher RI, Gaynor ER, Dahlberg S, et al: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328:1002-1006, 1993
2. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987-994, 1993
3. Pettengell R, Crowther D: Haemopoietic growth factors and dose intensity in high-grade and intermediate-grade lymphoma. Ann Oncol 5:S133-S141, 1994 (suppl 2)
4. Armitage JO: Treatment of non-Hodgkin's lymphoma. N Engl J Med 328:1023-1030, 1993
5. Pettengell R, Gurney H, Radford JA, et al: Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: A randomized controlled trial. Blood 80:1430-1436, 1992
6. Radford JA, Whelan JS, Rohatiner AZS, et al: Weekly VAPEC-B chemotherapy for high grade non-Hodgkin's lymphoma: Results of treatment in 184 patients. Ann Oncol 5:147-151, 1994
7. Pettengell R, Morgenstern GR, Woll PJ, et al: Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 82:3770-3777, 1993
8. Pettengell R, Testa NG, Swindell R, et al: Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood 82:2239-2248, 1993
9. Lister TA, Crowther D, Sutcliffe SB, et al: Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 7:1630-1636, 1989
10. Coiffier B, Philip T, Burnett AK, et al: Consensus conference on intensive chemotherapy plus hematopoietic stem-cell transplantation in malignancies: Lyon, France, June 4-6, 1993. J Clin Oncol 12:226-231, 1994
11. Tura S, Zinzani PL, Mazza P, et al: ABMT vs DHAP in residual disease following third generation regimens for aggressive non-Hodgkin's lymphomas. Blood 80:157a, 1992 (suppl 1, abstr)
12. Mazza P, Tura S, Zinzani PL, et al: A multicenter randomized study on aggressive non-Hodgkin's lymphomas: An up-dated follow-up. Proc Am Soc Clin Oncol 12:362, 1993 (abstr)
13. Haioun C, Lepage E, Gisselbrecht C, et al: Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma in first complete remission: A study of 464 patients. J Clin Oncol 12:2543-2551, 1994
14. Verdonck LF, van Putten WLJ, Hagenbeek A, et al: Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N Engl J Med 332:1045-1051, 1995
15. Gianni AM, Bregni M, Siena S, et al: 5-year update of the Milan Cancer Institute randomized trial of comparison of high-dose sequential (HDS) vs MACOP-B therapy for diffuse large-cell lymphomas. Proc Am Soc Clin Oncol 13:373, 1994 (abstr)
16. Tura S, Mazza P, Gherlinzoni F, et al: High-dose therapy followed by autologous bone marrow transplantation (ABMT) in previously untreated non-Hodgkin's lymphoma. Scand J Haematol 37:347-352, 1986
17. Gulati SC, Shank B, Black P, et al: Autologous bone marrow transplantation for patients with poor prognosis lymphoma. J Clin Oncol 6:1303-1313, 1988
18. Philip T, Armitage JO, Spitzer G, et al: High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med 316:1493-1498, 1987
19. Colombat P, Gorin N-C, Lemonnier M-P, et al: The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas. J Clin Oncol 8:630-637, 1990
20. Freedman AS, Takvorian T, Anderson KC, et al: Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: Very low treatment-related mortality in 100 patients in sensitive relapse. J Clin Oncol 8:784-791, 1990
21. Tavassoli M, Konno M, Shiota Y, et al: Enhancement of the grafting efficiency of transplanted marrow cells by preincubation with interleukin-3 and granulocyte-macrophage colony-stimulating factor. Blood 77:1599-1606, 1991
22. McMillan AK, Goldstone AH: Autologous bone marrow transplantation for non-Hodgkin's lymphoma. Eur J Haematol 46:129-135, 1991
23. Baro J, Richard C, Calavia J, et al: Autologous bone marrow transplantation as consolidation therapy for non-Hodgkin's lymphoma patients with poor prognostic features. Bone Marrow Transplant 8:283-289, 1991
24. Nademanee A, Schmidt GM, O'Donnell MR, et al: High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: A pilot study. Blood 80:1130-1134, 1992
25. Hagenbeek A, Verdonck L, Sonneveld P, et al: CHOP chemotherapy versus autologous bone marrow transplantation in slowly responding patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma. Blood 82:332a, 1993 (suppl 1, abstr 1311)
26. Sweetenham JW, Proctor SJ, Blaise D, et al: High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high grade non-Hodgkin's lymphoma: The EBMT experience. Ann Oncol 5:S155-S159, 1994 (suppl 2)